These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23401268)

  • 1. Monitoring binding of HIV-1 capsid assembly inhibitors using (19)F ligand-and (15)N protein-based NMR and X-ray crystallography: early hit validation of a benzodiazepine series.
    Goudreau N; Coulombe R; Faucher AM; Grand-Maître C; Lacoste JE; Lemke CT; Malenfant E; Bousquet Y; Fader L; Simoneau B; Mercier JF; Titolo S; Mason SW
    ChemMedChem; 2013 Mar; 8(3):405-14. PubMed ID: 23401268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
    Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
    ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization.
    Lemke CT; Titolo S; Goudreau N; Faucher AM; Mason SW; Bonneau P
    Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1115-23. PubMed ID: 23695256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.
    Fader LD; Landry S; Morin S; Kawai SH; Bousquet Y; Hucke O; Goudreau N; Lemke CT; Bonneau P; Titolo S; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3396-400. PubMed ID: 23583513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
    Fader LD; Landry S; Goulet S; Morin S; Kawai SH; Bousquet Y; Dion I; Hucke O; Goudreau N; Lemke CT; Rancourt J; Bonneau P; Titolo S; Amad M; Garneau M; Duan J; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3401-5. PubMed ID: 23601710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
    Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
    J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
    Neira JL
    FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV-CA Binding Fragments.
    Lang S; Fletcher DA; Petit AP; Luise N; Fyfe P; Zuccotto F; Porter D; Hope A; Bellany F; Kerr C; Mackenzie CJ; Wyatt PG; Gray DW
    ChemMedChem; 2024 Jul; 19(13):e202400025. PubMed ID: 38581280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, structural characterization by IR, (1) H, (13) C, (15) N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors.
    Samal RP; Khedkar VM; Pissurlenkar RR; Bwalya AG; Tasdemir D; Joshi RA; Rajamohanan PR; Puranik VG; Coutinho EC
    Chem Biol Drug Des; 2013 Jun; 81(6):715-29. PubMed ID: 23398677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
    Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
    Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli LysU is a potential surrogate for human lysyl tRNA synthetase in interactions with the C-terminal domain of HIV-1 capsid protein.
    Boonyalai N; Pullen JR; Abdul Wahab MF; Wright M; Miller AD
    Org Biomol Chem; 2013 Jan; 11(4):612-20. PubMed ID: 23208549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor.
    Ternois F; Sticht J; Duquerroy S; Kräusslich HG; Rey FA
    Nat Struct Mol Biol; 2005 Aug; 12(8):678-82. PubMed ID: 16041386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP.
    Evrard-Todeschi N; Gharbi-Benarous J; Bertho G; Coadou G; Megy S; Benarous R; Girault JP
    Peptides; 2006 Jan; 27(1):194-210. PubMed ID: 16165251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of ligands for Nurr1 by combined use of NMR screening with different isotopic and spin-labeling strategies.
    Poppe L; Harvey TS; Mohr C; Zondlo J; Tegley CM; Nuanmanee O; Cheetham J
    J Biomol Screen; 2007 Apr; 12(3):301-11. PubMed ID: 17438066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.
    Enríquez-Navas PM; Marradi M; Padro D; Angulo J; Penadés S
    Chemistry; 2011 Feb; 17(5):1547-60. PubMed ID: 21268157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the HIV-1 full-length capsid protein in a conformationally trapped unassembled state induced by small-molecule binding.
    Du S; Betts L; Yang R; Shi H; Concel J; Ahn J; Aiken C; Zhang P; Yeh JI
    J Mol Biol; 2011 Feb; 406(3):371-86. PubMed ID: 21146540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of an antiviral ankyrin targeting the HIV-1 capsid and molecular modeling of the ankyrin-capsid complex.
    Praditwongwan W; Chuankhayan P; Saoin S; Wisitponchai T; Lee VS; Nangola S; Hong SS; Minard P; Boulanger P; Chen CJ; Tayapiwatana C
    J Comput Aided Mol Des; 2014 Aug; 28(8):869-84. PubMed ID: 24997121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trimer of dimers is the basic building block for human immunodeficiency virus-1 capsid assembly.
    Tsiang M; Niedziela-Majka A; Hung M; Jin D; Hu E; Yant S; Samuel D; Liu X; Sakowicz R
    Biochemistry; 2012 Jun; 51(22):4416-28. PubMed ID: 22564075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of N-terminal domain charged residues on the assembly and stability of HIV-1 CA.
    Douglas CC; Thomas D; Lanman J; Prevelige PE
    Biochemistry; 2004 Aug; 43(32):10435-41. PubMed ID: 15301542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging.
    Morellet N; Druillennec S; Lenoir C; Bouaziz S; Roques BP
    Protein Sci; 2005 Feb; 14(2):375-86. PubMed ID: 15659370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.